Literature DB >> 29340561

Generic Substitution Rates of Oral Contraceptives and Associated Out-of-Pocket Cost Savings Between January 2010 and December 2014.

Mark Chee1, James X Zhang2, Samantha Ngooi2, Christopher Moriates3, Neel Shah4, Vineet M Arora2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29340561      PMCID： PMC5876818          DOI： 10.1001/jamainternmed.2017.7849

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  3 in total

1.  Estimation of Potential Savings Through Therapeutic Substitution.

Authors:  Michael E Johansen; Caroline Richardson
Journal:  JAMA Intern Med       Date:  2016-06-01       Impact factor: 21.873

2.  Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995.

Authors:  Jo Jones; William Mosher; Kimberly Daniels
Journal:  Natl Health Stat Report       Date:  2012-10-18

3.  Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.

Authors:  Jennifer S Haas; Kathryn A Phillips; Eric P Gerstenberger; Andrew C Seger
Journal:  Ann Intern Med       Date:  2005-06-07       Impact factor: 25.391
  3 in total
  3 in total

1.  Development and testing of a module to promote generic oral contraceptive prescribing among nurse practitioners.

Authors:  Mark Chee; Gena Lenti; Jeanne Farnan; Michelle Cook; Arlene Weissman; September Wallingford; Christopher Moriates; Neel Shah; Shalini Lynch; Marilyn Stebbins; Samantha Ngooi; Allison Norenberg; Steven Millard; Anita Samarth; James X Zhang; David O Meltzer; Chris Tracy; Vineet M Arora
Journal:  J Am Assoc Nurse Pract       Date:  2020-01       Impact factor: 1.495

2.  Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition.

Authors:  James X Zhang
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

3.  Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.

Authors:  Chana A Sacks; Victor L Van de Wiele; Lisa A Fulchino; Lajja Patel; Aaron S Kesselheim; Ameet Sarpatwari
Journal:  JAMA Intern Med       Date:  2021-01-01       Impact factor: 21.873
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.